Abstract
Polyclonal anti-idiotype antibodies (pAb2/m) for microcystin leucine−arginine variant (MCYST-LR) were generated from ascites after immunization with affinity-purified Fab fragment of rabbit polyclonal antibodies (pAb1/r) against MCYST-LR to BALB/c mice. Competitive direct enzyme-linked immunosorbent assay (cd-ELISA) revealed that the binding of free MCYST-LR to solid-phase pAb1/r was inhibited by affinity-purified pAb2/m. pAb2/m can be used as MCYST-LR surrogate in the ELISA. Using the purified pAb2/m as immunogen, polyclonal anti-anti-idiotype antibodies (pAb3/r), which have characteristics similar to those of original pAb1/r, were generated in rabbits. In the pAb3/r-based ELISA, the concentrations causing 50% inhibition (IC50) of binding of MCYST-LR−horseradish peroxidase (MCYST−HRP) to the solid-phase pAb3 by MCYST-LR, MCYST−arginine−arginine variant (MCYST-RR), MCYST−tyrosine−arginine variant (MCYST-YR), and nodularin (NODLN) were 0.7, 24.4, 19.2, and 24.3 ng/mL, respectively. pAb3/r showed a dose-dependent neutralization of the inhibitory effect of MCYST-LR to protein phosphatase 1 (PP1) in an in vitro assay system. pAb2/m had no effect on PP1 activities. Keywords: Antibody; anti-idiotype; microcystin-LR; PP1; ELISA
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
